Chromium Supplementation in Women with Clomiphene Citrate-Resistant Polycystic Ovary Syndrome

Not Applicable

• Conditions: Fertility-female; Polycystic Ovarian Syndrome, PCOS

• Registration Number: PACTR201611001856174
• Lead Sponsor: Cairo University- Kasr Alaini hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-11-09
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

PCOS
Age 18-40
clomiphene citrate resistant
Infertile

Exclusion Criteria

Thyroid hypo/hyperfunction
Hyperprolactinemia
Cushing syndrome)
Others factors causing infertility
Fasting hyperglycemia
Elevated liver enzymes
History of cardiac disease.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ovulation rate after 3-cycle treatment

Secondary Outcome Measures

Name	Time	Method
Secondary outcome measures were the effect of chromium supplementation on insulin, FSH and LH levels after treatment.